Solesence (SLSN) Research & Development (2010 - 2026)

Solesence (SLSN) has reported Research & Development for 17 consecutive years, with $947000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 0.84% year-over-year to $947000.0; the trailing twelve-month figure through Jun 2026 stood at $4.1 million (up 1.78% YoY), and the FY2025 full-year result was $4.1 million, up 6.59% from the prior year.
• Research & Development fell to $947000.0 in Q2 2026 per SLSN's latest filing, from $1.0 million in the prior quarter.
• Across five years, Research & Development topped out at $1.1 million in Q4 2024 and bottomed at $666000.0 in Q1 2022.
• Historically, Research & Development has averaged $932666.7 across 5 years, with a median of $962500.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Research & Development surged 50.6% in 2023, then declined 12.82% in 2024.
• Over 5 years, Research & Development stood at $727000.0 in 2022, then grew by 7.98% to $785000.0 in 2023, then jumped by 38.98% to $1.1 million in 2024, then retreated by 5.13% to $1.0 million in 2025, then declined by 8.5% to $947000.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $947000.0, $1.0 million, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.